MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Neural mechanisms underlying step initiation failure in patients with Parkinson’s disease and freezing of gait

    M. Gilat, M. Georgiades, J.M. Shine, K.A. Ehgoetz Martens, C.C. Walton, J.M. Hall, S.J.G. Lewis (Sydney, Australia)

    Objective: To investigate the neural mechanisms underlying gait initiation failure in Parkinson's disease patients with Freezing of Gait. Background: Freezing of Gait (FOG) is a…
  • 2016 International Congress

    Comparison of DAT and DOPA PET tracer for assessing severity and progression in patients with Parkinson’s disease

    W. Li, N.P. Lao-Kaim, A.A. Roussakis, A. Martin-Bastida, C. Loane, N. Valle-Guzman, Z. Kefalopoulou, M. Politis, T. Foltynie, R.A. Barker, P. Piccini (London, United Kingdom)

    Objective: The aims of this study were to quantify striatal uptake of 18F-DOPA and 11C-PE2I in the same group of PD patients, to assess the…
  • 2016 International Congress

    Diagnostic reliability of clinical symptoms in patients with incomplete manifestation of the triad of parkinsonism compared to 18F-DOPA PET-CT MRI imaging

    C. Peralta, T. Soto Depetris, A. Perez, F. Biafore, J. Gili, A. Valda, D. Menna, M. Aguilar, H. Corradini, M. Bastianello (Caba, Argentina)

    Objective: To describe the diagnostic reliability of the triad of clinical symptoms compared to the uptake of 18 F-DOPA PET-CT fusion MRI scan. To compare…
  • 2016 International Congress

    The effect of an eight-week mindfulness training intervention on emotion related brain activation in people with Parkinson’s disease

    B.A. Pickut, W. Van Hecke, P. Cras, E. Kerckhofs, S. Vanneste, D. Crosiers, P. Marien, P.M. Parizel (Grand Rapids, MI, USA)

    Objective: The aim of the current study is to investigate the effect of an eight-week mindfulness training intervention on emotion related brain activation in people…
  • 2016 International Congress

    Is the selection of stepping impaired in PD in ON state?

    C. Stummer, E. Mallia, J. Rothwell, B.R. Bloem, V. Weerdesteyn (Nijmegen, Netherlands)

    Objective: To compare the selection of stepping actions during a probability reaction time task in people with Parkinson's disease (PD) in the ON state with…
  • 2016 International Congress

    Intraoperative localization of beta band and high-frequency oscillations within the subthalamic nucleus

    B.C.M. van Wijk, A. Pogosyan, T. Foltynie, M.I. Hariz, P. Limousin, L. Zrinzo, P. Brown, V. Litvak (London, United Kingdom)

    Objective: To investigate whether beta band activity (13-30Hz) and high-frequency oscillations (150-400Hz) arise from the same spatial location within the subthalamic nucleus (STN) of Parkinson's…
  • 2016 International Congress

    Detection of primary olfactory cortex dysfunction in early-stage Parkinson’s disease

    J. Wang, T. Subramanian, Q.X. Yang (Hershey, PA, USA)

    Objective: To detect the functional changes of primary olfactory cortex (POC) in the early-stage Parkinson's disease (PD) using functional magnetic resonance imaging (fMRI). Background: Olfactory…
  • 2016 International Congress

    Diagnosis and management of dementia with Lewy bodies: Influence of concomitant cerebrovascular disease

    A. Chimagomedova, E. Vasenina, O. Levin (Moscow, Russia)

    Objective: We assume that the cerebrovascular disease might influence on the course and clinical features of dementia with Lewy bodies (DLB). The aim of this…
  • 2016 International Congress

    Relationship of MDS-UPDRS non-motor symptoms to cognitive functioning in patients with Parkinson’s disease

    B.A. Bernard, D. Carns, G.T. Stebbins, J.G. Goldman, C.G. Goetz (Chicago, IL, USA)

    Objective: To evaluate the relationship among individual items from the MDS-UPDRS Part I and measures of cognitive functioning in patients with PD. Background: Non-motor symptoms…
  • 2016 International Congress

    Dopaminergic drug management in Parkinson’s disease: Gait and language function show correlation during treatment

    H. Murakami, A. Futamura, T. Kuroda, S. Ishigaki, M. Kezuka, K. Ono, M. Kawamura (Tokyo, Japan)

    Objective: We examined the effects of dopaminergic medication adjustment on cognitive function in Parkinson's disease (PD) patients without apparent dementia (Mini-Mental State Examination score of…
  • « Previous Page
  • 1
  • …
  • 202
  • 203
  • 204
  • 205
  • 206
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley